Recombinant DNA technology

Written by

in

 

Recombinant DNA Technology: Workflow & Clinical Utility

Workflow Step Molecular & Technical Event Key Enzyme / Tool
1. Cleavage Restriction endonucleases recognize specific palindromic sequences in both the source DNA (target gene) and the vector (plasmid). Restriction Enzymes (e.g., EcoRI).
2. Ligation The target gene fragment is inserted into the cut vector. DNA ligase forms covalent phosphodiester bonds to join the sugar-phosphate backbones. DNA Ligase.
3. Transformation The recombinant plasmid is introduced into a host cell (typically E. coli) via heat shock or electroporation. Competent bacterial cells.
4. Selection Transformed bacteria are plated on selective media (often containing antibiotics) to isolate cells that successfully took up the plasmid. Antibiotic resistance markers.
High-Yield Core Realities:

  • cDNA Libraries vs. Genomic Libraries: If the goal is to express a human protein in a prokaryotic system (which lacks splicing machinery), one must use cDNA (complementary DNA). Reverse transcriptase creates cDNA from mature mRNA, which contains only exons, effectively skipping the intron-splicing requirement that bacteria cannot perform.
  • Restriction Enzyme Logic: Restriction enzymes typically generate “sticky ends” (staggered cuts) or “blunt ends” (straight cuts). Sticky ends are significantly more efficient for cloning because they allow for specific base-pairing hybridization between the gene fragment and the vector prior to ligation.
  • Clinical Therapeutics Production: Recombinant DNA technology is the engine behind modern pharmacology. Key examples include:

    • Insulin: Production of human insulin in bacteria.

    • Growth Hormone: Recombinant somatotropin for pediatric growth disorders.

    • Vaccines: Hepatitis B surface antigen produced via recombinant yeast.

  • Vector Design Features: A successful cloning vector requires three non-negotiable components:

    1. An **Origin of Replication (ori)** to allow independent replication within the host.

    2. A **Multiple Cloning Site (MCS)** containing unique restriction sites for easy insertion.

    3. A **Selectable Marker** (e.g., ampicillin resistance gene) to allow identification of host cells that carry the plasmid.